Company Search:
Advanced Search
Sponsored Links
Pluristem Therapeutics Incorporation. Company Snapshot
Pluristem Therapeutics Incorporation. operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Pluristem Therapeutics Incorporation. with three other companies in this sector in the United States: Windtree Therapeutics Inc (2016 sales of $2.04 million of which 100% was Respiratory Therapies), Organovo Holdings Incorporated ($1.48 million of which 100% was Developing and Commercializing Human Tis), and Oncobiologics Inc ($2.98 million ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Pluristem Therapeutics Incorporation.
  Stock Performance Chart for Pluristem Therapeutics Incorporation.
  Stock Data: Recent Stock Performance:
  Current Price (11/17/2017): 1.49
(Figures in U.S. Dollars)
1 Week 4.2%   13 Weeks -15.6%  
4 Weeks 22.1%   52 Weeks -3.9%  
Pluristem Therapeutics Incorporation. Key Data:
  Ticker: PSTI Country: Israel
  Exchanges: NAS OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 2,847,000
(Year Ending Jan 2017).
Employees: 183
  Currency: U.S. Dollars Market Cap: 146,293,750
  Fiscal Yr Ends: June Shares Outstanding: 98,183,725
  Share Type: Common Closely Held Shares: 6,625,820
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.